Allegro Ophthalmics Reports Phase II Data for Luminate

Allegro Ophthalmics: First-in-Class Anti-Integrin Agent (OIS@ASRS 2016)Подробнее

Allegro Ophthalmics Preps for Phase III of RisuteganibПодробнее

Allegro’s Luminate Achieves Primary Endpoint in DME Trial (OIS@AAO 2016)Подробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

ForSight Reports on Phase II Bimatoprost Ring ResultsПодробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019Подробнее

Allegro OphthalmicsПодробнее

Allegro Plans for Phase III of LuminateПодробнее

Allegro Ophthalmics - OIS@AAO 2015Подробнее

Allegro ventures into the anterior segmentПодробнее

Explore The Possibilities of Angiostamp™ 800Подробнее

FDA Approval of Extended Range Intraocular LensПодробнее

Digital Retinal Imaging, Getting a Closer Look into The Health of Your EyesПодробнее

[LOAA] LOAA dPCR for SARS-CoV-2 detectionПодробнее

Ocunexus Seeking Support for Phase IIb of Oral GA AgentПодробнее

Transform your system to Philips AzurionПодробнее

Hyperreflective Foci and Outer Retinal TubulationПодробнее

Novel advanced 3D neuro-imaging in the Angio Suite for faster treatment of ELVOsПодробнее